CN109280711A - LAMP detection primer group, detection kit and its detection method of mycobacterium kansasii - Google Patents

LAMP detection primer group, detection kit and its detection method of mycobacterium kansasii Download PDF

Info

Publication number
CN109280711A
CN109280711A CN201810473250.5A CN201810473250A CN109280711A CN 109280711 A CN109280711 A CN 109280711A CN 201810473250 A CN201810473250 A CN 201810473250A CN 109280711 A CN109280711 A CN 109280711A
Authority
CN
China
Prior art keywords
primer
detection
mycobacterium kansasii
lamp
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810473250.5A
Other languages
Chinese (zh)
Inventor
刘厚明
尹小毛
单万水
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Third Peoples Hospital of Shenzhen
Original Assignee
Third Peoples Hospital of Shenzhen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Third Peoples Hospital of Shenzhen filed Critical Third Peoples Hospital of Shenzhen
Priority to CN201810473250.5A priority Critical patent/CN109280711A/en
Publication of CN109280711A publication Critical patent/CN109280711A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions

Abstract

The present invention provides a kind of LAMP primer group for detecting mycobacterium kansasii, including outer primer F3, outer primer B3, inner primer FIP, inner primer BIP, ring primer LF and ring primer LB.The present invention also provides detection kits and its detection method comprising above-mentioned primer sets.Detection kit includes primer liquid, reaction solution, archaeal dna polymerase, yin and yang attribute control and fluorescent dye (or color developing agent).Detection method is the DNA by extracting sample to be tested, then in the presence of archaeal dna polymerase and primer sets, to sample DNA templates in 65 DEG C or so progress isothermal duplications, determine in measuring samples whether contain mycobacterium kansasii finally by color change in real-time fluorescence quantitative PCR instrument detection fluorescence or addition color developing agent observation tube.Kit provided by the invention and detection method have specificity and sensitivity well, and amplification is quickly, efficiently, easily operated, can be used for the quick detection of mycobacterium kansasii in clinical samples.

Description

LAMP detection primer group, detection kit and its detection of mycobacterium kansasii Method
Technical field
The present invention relates to the quick detections of technical field of molecular biology more particularly to mycobacterium kansasii, specially A kind of LAMP detection primer group, detection kit and its detection method of mycobacterium kansasii.
Background technique
Mycobacterium kansasii is a kind of slow growth non-tuberculous mycobacteria, belongs to I group in Runyon classification, i.e. light Chromogenic group.The micro- sem observation of direct smear is shown in that the bacterium is coarseer, also visible particulate bacillus form and the arrangement of thallus fence sample. After mycobacterium kansasii grows about 6 weeks on suitable culture medium (such as Michaelis culture medium, Russell medium), it can be formed thick Rough or smooth medium sized yellow color colonies, as incubation time extends, colony colour is slowly changed into reddish orange.Kansas Mycobacteria may be present in water and soil in environment, and the most common source is tap water, will not generally infect the mankind and cause Disease and the human world is caused to propagate.But when under special circumstances, if any basic tuberculosis or patients with low immunity, which can cause The outer disease of pulmonary disease, lung even whole body disseminated infections.
Mycobacterium kansasii infects common clinical symptoms and includes cough, pectoralgia, hemoptysis and expiratory dyspnea etc., common Imageology is unilateral upper lung section shade, these performances and phthisical clinical symptoms and Imageology all compared with class Seemingly, therefore such diagnosis basis all lacks specificity in terms of mycobacterium kansasii Infect And Diagnose.In terms of laboratory diagnosis, lead to Mycobacterium kansasii and other mycobacterias (including mycobacterium tuberculosis compound) can be identified by crossing culture and biochemical identification, but This tradition discrimination method is cumbersome and takes a long time, and the repeatability and stability of result are not satisfactory;Interferon Release test be considered as identify tuberculosis and Nontuberculous mycobacterial infections advantageous weapon, but due to mycobacterium kansasii with Mycobacterium tuberculosis is the same to generate CFP-10 and EAST-6, therefore interferon release test can not identify Kansas branch bar Bacterium disease and tuberculosis;Molecular biology method can rapidly identify mycobacterium kansasii, common method include regular-PCR, Real-time PCR and DNA probe hybridization etc., but these methods are required using specific apparatus such as PCR instruments at present, and some methods make Amplification target position also lacks good specificity, these deficiencies cause clinical new to the detection of research and development application mycobacterium kansasii The demand of method is more urgent.
Loop-mediated isothermal amplification technique (Loop-mediated isothermal amplification, LAMP) is this generation The new nucleic acid amplification technologies of one kind just to come out of recording, the technology carry out being not necessarily to transformation temperature when nucleic acid amplification, under isothermal conditions Entire amplified reaction can be completed, and final result judgement can observe by the naked eye color change and can be realized, therefore LAMP is not needed being capable of the special installations such as accurate temperature controlling and the PCR instrument of progress fluorescence monitoring.Because LAMP can make up for it PCR method The deficiency of a little aspects, so the technology has been widely applied in terms of mycobacterium tuberculosis clinical detection, but is bearing at present Application is not yet received in Sa Si mycobacteria context of detection LAMP.
Summary of the invention
In view of this, technical problem solved by the invention is that the LAMP detection for providing a kind of mycobacterium kansasii is drawn Object group.
Technical problem solved by the invention, which also resides in, provides a kind of LAMP detection kit of mycobacterium kansasii.
Technical problem solved by the invention, which also resides in, provides a kind of utilization above-mentioned mycobacterium kansasii LAMP detection examination The method of agent box detection mycobacterium kansasii.
In order to solve the above-mentioned technical problem, the technical solution adopted in the present invention is as follows:
On the one hand, the invention discloses a kind of LAMP detection primer groups of mycobacterium kansasii, for Kansas branch The distinctive ECHT gene coded sequence of bacillus designs and optimizes, and the detection primer group includes outer primer F3, outer primer B3, interior draws Object FIP, inner primer BIP, ring primer LF and ring primer LB, nucleic acid sequence difference are as follows:
Outer primer F3:5 '-GACTGTTGGCGAGTTGGT-3 '
Outer primer B3:5 '-GTCCTGGAACGTCTGCTC-3 '
Inner primer FIP:5 '-GGTGTGGCACATTGCGACAGATATAACTCGAACAGCAC-3 '
Inner primer BIP:5 '-CGGATCAGCGGTATGACGGCCGGCTGCCCGATTAGAT-3 '
Ring primer LF:5 '-GTTCTGCGACGGCGATTC-3 '
Ring primer LB:5 '-GGGATGCGTTGTCCACCA-3 '.
Preferably, the outer primer F3, outer primer B3, inner primer FIP, inner primer BIP, ring primer LF and ring primer LB exist Molar ratio in reaction system is 1:1:4:4:2:2.
On the other hand, the invention also discloses a kind of LAMP detection kit of mycobacterium kansasii, the detection reagents Contain the LAMP detection primer group of mycobacterium kansasii as claimed in claim 1 or 2 in box.
Preferably, which is characterized in that further include some or all of of following component: (1) archaeal dna polymerase;(2) LAMP is anti- Answer liquid;(2) fluorescent dye or color developing agent;(3) positive control and negative control.
Preferably, the archaeal dna polymerase is Bst archaeal dna polymerase;LAMP reaction solution include dNTP, reaction buffer, MgSO4 and glycine betaine.
Preferably, positive control is the carrier cloning containing mycobacterium kansasii ECHT genetic fragment, and negative control is Water or other solvents without mycobacterium kansasii ECHT genetic fragment.
Preferably, the fluorescent dye is SYBR green, and the color developing agent is hydroxynaphthol blue.
In a preferred embodiment of the invention, the LAMP detection kit of mycobacterium kansasii of the invention, including it is following Ingredient:
(1) primer sets: including LAMP detection primer group described in claim 1, outer primer, inner primer and ring primer it is dense Degree is 10 μM;
(2) reaction solution: including dNTP, reaction buffer, MgSO4 and glycine betaine, when use, needs equimultiple to dilute;
(3) Bst archaeal dna polymerase: concentration is 0.16U/ μ L;
(4) fluorescent dye or color developing agent: fluorescent dye is SYBR green, and color developing agent is hydroxynaphthol blue (HNB);
(5) sealing fluid: for closing paraffin oil;
(6) it is enucleated sour water: for supplementing reaction volume.
Further more, detecting Kansas using above-mentioned mycobacterium kansasii LAMP detection kit the invention also discloses a kind of The method of mycobacteria, which comprises the following steps:
(1) sample DNA the extraction of measuring samples DNA: is extracted using boiling lysis.(a) according to sputum specimen sliminess Difference, be suitably added the digestive juice of 1~2 times of volume, then vortex oscillation 30s, place 15min under room temperature.Bronchus The processing of flushing liquor sample is the same with sputum specimen.1~2 times of volume is suitably added after pleural effusion sample 5000rpm centrifugation 15min The digestive juice of volume, remainder handle same sputum specimen.Swab specimen is first put into 1ml physiological saline, takes out swab after rotating repeatedly, Then 5000rpm is centrifuged 15min, and 1ml digestive juice is added, and remainder handles same sputum specimen.(b) the postdigestive liquid of 1ml is drawn extremely In 1.5ml microcentrifugal tube, 13000rpm is centrifuged 10min.(c) 1ml physiological saline, 13000g centrifugation is added after discarding supernatant liquid 10min.(d) step (c) is repeated after discarding supernatant.Supernatant is removed after centrifugation, 40 μ l DNA extracting solutions are added, and oscillation mixes 2000rpm is centrifuged 5s afterwards, then 37 DEG C of warm bath 30min, then 100 DEG C of heating 10min, and 13000rpm is centrifuged 10min after cooling. (e) supernatant comprising DNA profiling is transferred to another after being centrifuged to go in the 1.5ml microcentrifugal tube of nucleic acid, sets -20 DEG C of guarantors It deposits spare;
(2) isothermal amplification: the measuring samples DNA profiling obtained in 2 μ L steps (1) or positive and negative control is taken to add Enter and mixed in LAMP reaction system, 65 DEG C of isothermal reaction 50min are expanded, and then 80 DEG C of isothermal reaction 10min terminate reaction; LAMP detection primer group comprising mycobacterium kansasii described in claims 1 or 2 in the LAMP reaction system;
(3) result judges: being judged by the real-time fluorescence detection data of analysis of fluorescence quantitative PCR apparatus, or passed through The variation that liquid color in color developing agent observation PCR pipe is added carrys out judging result.
Preferably, the LAMP reaction system is to contain in 20 μ L reaction systems:
Outer primer F3, outer primer B3, inner primer FIP, inner primer BIP, ring primer LF and ring primer LB concentration are 10 μM, Additional amount is respectively 0.5 μ L, 0.5 μ L, 2 μ L, 2 μ L, 1 μ L, 1 μ L;
The additional amount of 0.16U/ μ L Bst archaeal dna polymerase is 0.4 μ L;
0.4 μ L of fluorescent dye or color developing agent;
10 μ L of reaction solution includes 4mM dNTP, 12mM MgSO in reaction solution4, 1.6mM glycine betaine, 40mM Tris-HCl, 20mM KCl、20mM(NH4)SO4, 0.1%TritonX-100;
The measuring samples DNA extracted in 2 μ L steps (1);
With deionized water polishing to 20 μ L.
As the important indicator for influencing detection effect, the selection of testing goal segment is most important.In calculating detection, examine The length for considering mycobacterium kansasii, using complete series detection and unrealistic, time and effort consuming and may be to testing result, this hair It is bright by consulting literatures and search Genebank database find the distinctive nucleic acid sequence of mycobacterium kansasii, and by with its The detection of its target gene is compared to verify the specificity of the nucleic acid sequence, finally the determining peculiar nucleic acid of mycobacterium kansasii Sequence is target fragment of the ECHT gene order as amplification, can in conjunction with the technical effect in above-mentioned analysis and the embodiment of the present invention Know, the present invention include at least it is following the utility model has the advantages that
(1) easy to operate: DNA extraction step is simple and effective, and template can be directly used for following amplification reaction, and isothermal duplication can Selection is not necessarily to the special installations such as PCR instrument;
(2) amplification is quick: isothermal duplication only needs 60min, after the completion of amplification result can direct interpretation, entire detection process institute It takes time within 2h.
(3) specificity is high: detection primer group includes six specific primers, can only effectively expand mycobacterium kansasii, Mycobacterium tuberculosis compound, Mycobacterium chelonei, mycobacterium abscessus, mycobacterium avium and branch bar intracellular cannot effectively be expanded Other pathogen such as bacterium.
(4) sensitivity is high: the minimum that can be detected is 100 copies.
(5) avoid pollution: fluorescent dye or color developing agent are added before the reaction, without addition of uncapping after reaction, can effectively prevent The only diffusion and pollution of amplified production.
Detailed description of the invention
Fig. 1 is specific analysis of fluorescence curve graph.S type curve is the amplification curve of mycobacterium kansasii.
Fig. 2 is that specificity analysis visually observes figure.Upper row's PCR pipe respectively corresponds mycobacterium kansasii, knot from left to right Core mycobacteria, Mycobacterium chelonei, mycobacterium abscessus, mycobacterium avium, lower row's PCR pipe respectively correspond intracellular point from left to right Branch bacillus, mycobacterium smegmatis, escherichia coli, staphylococcus aureus, Candida albicans.
Fig. 3 is sensitivity analysis fluorescence curve figure.From left to right three S type curves be respectively 106copies/ μ L, The amplification curve of 104copies/ μ L, 102copies/ μ L concentration template.
Fig. 4 is that sensitivity analysis visually observes figure.The template concentrations of PCR reaction tube amplification from left to right are respectively as follows: 106copies/μL、104copies/μL、102Copies/ μ L and 1copies/ μ L.
Fig. 5 is clinical samples detection fluorescence curve figure.9 parts of clinical samples are detected altogether, wherein 1 part of sample Kansas branch bar Bacterial examination is surveyed positive.The S type curve on the left side is positive quality control amplification curve.
Fig. 6 is that clinical samples detection visually observes figure.9 parts of clinical samples are detected altogether, wherein 1 part of sample Kansas branch bar Bacterial examination is surveyed positive.It is the positive pipe of clinical samples amplification that lower row's PCR pipe the 1st, which manages (from left to right), and the lower pipe of row's PCR pipe the 4th, 5 is (from a left side To the right side) it is respectively positive quality control and negative Quality Control amplification pipe.
Specific embodiment
Following embodiment further illustrates the contents of the present invention, but described example is that part of the invention is implemented Example, rather than whole embodiments, therefore should not be construed limitation of the present invention.Based on the embodiments of the present invention, noninvasive To the modifications or substitutions of the method for the present invention, step or condition under the premise of the property made labour, shall fall within the protection scope of the present invention.
Embodiment 1: design of primers
The distinctive gene order of mycobacterium kansasii is found by consulting literatures first, then in the Genebank of NCBI The gene order is searched in database and verifies its specificity, is then with the sequence using special LAMP primer design software Target gene carries out design of primers, and finally designed primer is analyzed and optimized on primer-blast.It is final to determine Primer sequence see SEQ ID No:1 to SEQ ID No:6 respectively.
The comparative test for verifying the peculiar gene order of mycobacterium kansasii includes following amplimer:
Hsp65F:5 '-CAGGAAGCAGTGCTGGAAGA-3 ' SEQ ID No:7;
Hsp65R:5 '-GTGCTCAAAGCCTCACCCTC-3 ' SEQ ID No:8;
ECHTF:5 '-AAACGGTGTGTCGCAATGTG-3 ' SEQ ID No:9;
ECHTR:5 '-GGATATGGCGGTCCCTTCTG-3 ' SEQ ID No:10;
The branches such as mycobacterium kansasii, mycobacterium tuberculosis and Mycobacterium chelonei are detected respectively using above-mentioned two pairs of primers Two kinds of target genes (i.e. hsp65 and ECHT gene) of bacillus clinical strain compare two kinds of target gene amplification positive findings and analyze it Accuracy, accuracy is higher, and the specificity for indicating the target gene augmentation detection mycobacterium kansasii is higher, also indicates that the target base Because being more suitable for being used for the detection of mycobacterium kansasii in clinical samples.
Embodiment 2: mycobacterium kansasii LAMP detection reaction system is established
Different isothermal amplification temperature (60 DEG C, 63 DEG C, 65 DEG C), different primers concentration (5 μM, 10 μM, 15 μM) are set With different additional amount Bst archaeal dna polymerases (0.2 μ L, 0.4 μ L, 0.6 μ L), more same template expands under each factor different condition The Ct value of increasing, primer concentration, Bst archaeal dna polymerase additional amount and the amplified reaction temperature of minimum Ct value can be obtained as originally The end reaction parameter of invention.
It has been determined that highly preferred mycobacterium kansasii LAMP detects reaction system and reaction condition by repetition test, I.e. isothermal duplication temperature is 65 DEG C;In 20 μ L reaction systems, outer primer F3, outer primer B3, inner primer FIP, inner primer BIP, Ring primer LF and ring primer LB concentration are 10 μM, and additional amount is respectively 0.5 μ L, 0.5 μ L, 2 μ L, 2 μ L, 1 μ L, 1 μ L, are being reacted Molar ratio in system is 1:1:4:4:2:2;The additional amount of 0.16U/ μ L Bst archaeal dna polymerase is 0.4 μ L.Specific additional amount It is as follows:
Ingredient names Additional amount (μ L) Ingredient names Additional amount (μ L)
Reaction solution 10 Bst archaeal dna polymerase 0.4
Outer primer 1 Fluorescent dye/color developing agent 0.4
Inner primer 4 Sample DNA 2
Ring primer 2 Add water polishing extremely 20
It include 4mM dNTP, 12mM MgSO in reaction solution4, 1.6mM glycine betaine, 40mM Tris-HCl, 20mM KCl, 20mM(NH4)SO4, 0.1%TritonX-100.
Embodiment 3: analysis Evaluation on specificity
Common mycobacteria and common common bacteria are chosen as test object and carrys out evaluation analysis specificity, specifically includes and bears Sa Si mycobacteria, mycobacterium tuberculosis, Mycobacterium chelonei, mycobacterium abscessus, mycobacterium avium, Mycobacterium intracellulare, shame 10 kinds of microorganisms such as dirty mycobacteria, escherichia coli, staphylococcus aureus, Candida albicans.As the result is shown (attached drawing 1, 2), the present invention fails to detect to other microorganisms other than above-mentioned mycobacterium kansasii, therefore the present invention has well Analysis specificity.
Embodiment 4: analytical sensitivity evaluation
10 are prepared using the plasmid for having connected target gene6copies/μL、104copies/μL、102Copies/ μ L and The template of 1copies/ μ L concentration, every kind of concentration take 1 μ L to carry out LAMP detection, observe by the naked eye color change and glimmering respectively Light PCR instrument monitors analysis of fluorescence and carries out result interpretation, using the detection limit of fluorescence analysis interpretation method as Monitoring lower-cut.Knot Fruit shows (such as Fig. 3,4) that the lower limit that the present invention detects ureaplasma urealyticum is 100 copies, therefore the present invention has good point Analyse sensitivity.
Embodiment 5: clinical samples detection
1, reagent prepares
(1) primer, reaction solution, Bst archaeal dna polymerase, fluorescent dye, color developing agent, stoning sour water, paraffin oil, feminine gender are right According to, positive control, the various composition of corresponding amount is taken to mix (specific additional amount is shown in embodiment 2), is saved at 4 DEG C after brief centrifugation standby With.
2, sample preparation
(1) according to the difference of sputum specimen sliminess, it is suitably added the digestive juice of 1~2 times of volume, then vortex oscillation 30s places 15min under room temperature.The processing of Bronchial washing sample is the same with sputum specimen.Pleural effusion sample The digestive juice of 1~2 times of volume volume is suitably added after 5000rpm centrifugation 15min, remainder handles same sputum specimen.Swab specimen is first It is put into 1mL physiological saline, takes out swab after rotating repeatedly, then 5000rpm is centrifuged 15min, and 1mL digestive juice is added, remaining Handle same sputum specimen.
(2) the postdigestive liquid of 1mL is drawn into 1.5mL microcentrifugal tube, and 13000rpm is centrifuged 10min.
(3) 1mL physiological saline is added after discarding supernatant liquid, 13000g is centrifuged 10min.It is primary to repeat this step.
(4) supernatant is removed after being centrifuged, and 40 μ L DNA extracting solutions are added, 2000rpm is centrifuged 5s after oscillation mixes, and then 37 DEG C warm bath 30min, then 100 DEG C of heating 10min, it is cooling after 13000rpm be centrifuged 10min.
(5) supernatant comprising DNA profiling another is transferred to after being centrifuged to go in the 1.5mL microcentrifugal tube of nucleic acid, - 20 DEG C are set if not expanding immediately to save backup.
3, sample is added
It takes the addition of 2 μ L templates to have in the PCR pipe of various reacted constituents and mix, marks good rear brief centrifugation.Using glimmering Fluorescent dye is added when optical analysis in the reaction system, color developing agent is then added in the reaction system when using observation method of naked eye HNB。
4, isothermal duplication
(1) fluorescence analysis: PCR reaction tube is put on the sample rack of fluorescence quantitative PCR instrument, the basis in analysis software Placement order works out sample names and yin and yang attribute control;Be arranged amplification condition are as follows: 65 DEG C of reaction 50min, 90 DEG C of reaction 10min, 25 DEG C of cooling 1min, fluorescence detection channel select the channel FAM;Using fluorescence quantitative PCR instrument monitoring and analysis of fluorescence signal, sample Amplification curve is S-type, and signal value is higher than threshold value and is just determined as the positive, no amplification curve or amplification curve is straight is determined as yin Property, it only just can be carried out sample results interpretation (such as Fig. 5) under the premise of yin and yang attribute results of comparison meets;
(2) observation method of naked eye: PCR reaction tube is put into 65 DEG C of reaction 50min in dry bath pot, then rises to 90 DEG C of reactions 10min, brief centrifugation after cooling;Visual results, navy blue are that amplification is negative, light blue positive to expand, only yin-yang Property results of comparison meet could interpretation sample amplification (such as Fig. 6).
Finally, it should be noted that the above embodiments are merely illustrative of the technical solutions of the present invention rather than protects to the present invention The limitation of range is protected, although the invention is described in detail with reference to the preferred embodiments, those skilled in the art should Understand, it can be with modification or equivalent replacement of the technical solution of the present invention are made, without departing from the essence of technical solution of the present invention And range.
Sequence table
<110>The Third People's Hospital of Shenzhen (hepatopathy research institute of Shenzhen)
<120>LAMP detection primer group, detection kit and its detection method of mycobacterium kansasii
<130> 2017
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 18
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 1
GACTGTTGGCGAGTTGGT 18
<210> 2
<211> 18
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 2
GTCCTGGAACGTCTGCTC 18
<210> 3
<211> 38
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 3
GGTGTGGCACATTGCGACAGATATAACTCGAACAG CAC 38
<210> 4
<211> 37
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 4
CGGATCAGCGGTATGACGGCCGGCTGCCCGATTAGAT 37
<210> 5
<211> 18
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 5
GTTCTGCGACGGCGATTC 18
<210> 6
<211> 18
<212> DNA
<213>artificial sequence (Artificial sequence)
<400> 6
GGGATGCGTTGTCCACCA 18

Claims (10)

1. a kind of LAMP detection primer group of mycobacterium kansasii, which is characterized in that distinctive for mycobacterium kansasii ECHT gene coded sequence designs and optimizes, and the detection primer group includes outer primer F3, outer primer B3, inner primer FIP, interior draws Object BIP, ring primer LF and ring primer LB, nucleic acid sequence difference are as follows:
Outer primer F3:5 '-GACTGTTGGCGAGTTGGT-3 '
Outer primer B3:5 '-GTCCTGGAACGTCTGCTC-3 '
Inner primer FIP:5 '-GGTGTGGCACATTGCGACAGATATAACTCGAACAGCAC-3 '
Inner primer BIP:5 '-CGGATCAGCGGTATGACGGCCGGCTGCCCGATTAGAT-3 '
Ring primer LF:5 '-GTTCTGCGACGGCGATTC-3 '
Ring primer LB:5 '-GGGATGCGTTGTCCACCA-3 '.
2. LAMP detection primer group according to claim 1, which is characterized in that it is characterized in that, outer primer F3, outer primer B3, inner primer FIP, inner primer BIP, the molar ratio of ring primer LF and ring primer LB in the reaction system are 1:1:4:4:2:2.
3. a kind of LAMP detection kit of mycobacterium kansasii, which is characterized in that containing such as right in the detection kit It is required that the LAMP detection primer group of mycobacterium kansasii described in 1 or 2.
4. according to the LAMP detection kit of claim 3 mycobacterium kansasii, which is characterized in that it is characterized in that, also wrapping Include some or all of of following component: (1) archaeal dna polymerase;(2) LAMP reaction solution;(2) fluorescent dye or color developing agent;(3) positive Property control and negative control.
5. the kit according to claim 4 based on intelligent constant-temperature amplification technique detection staphylococcus aureus, special Sign is: the archaeal dna polymerase is Bst archaeal dna polymerase;LAMP reaction solution includes dNTP, reaction buffer, MgSO4 and beet Alkali.
6. the kit according to claim 4 based on intelligent constant-temperature amplification technique detection staphylococcus aureus, special Sign is: positive control is the carrier cloning containing mycobacterium kansasii ECHT genetic fragment, and negative control is without bearing Sa The water or other solvents of this mycobacteria ECHT genetic fragment.
7. according to the LAMP detection kit of claim 3 mycobacterium kansasii, which is characterized in that the fluorescent dye is SYBR green, the color developing agent are hydroxynaphthol blue.
8. according to the LAMP detection kit of claim 3 mycobacterium kansasii, which is characterized in that including following component:
(1) primer sets: including LAMP detection primer group described in claim 1, and the concentration of outer primer, inner primer and ring primer is equal It is 10 μM;
(2) reaction solution: including dNTP, reaction buffer, MgSO4 and glycine betaine, when use, needs equimultiple to dilute;
(3) Bst archaeal dna polymerase: concentration is 0.16U/ μ L;
(4) fluorescent dye or color developing agent: fluorescent dye is SYBR green, and color developing agent is hydroxynaphthol blue (HNB);
(5) sealing fluid: for closing paraffin oil;
(6) it is enucleated sour water: for supplementing reaction volume.
9. a kind of method of mycobacterium kansasii LAMP detection kit detection mycobacterium kansasii, which is characterized in that packet Include following steps:
(1) sample DNA the extraction of measuring samples DNA: is extracted using boiling lysis.(a) according to the difference of sputum specimen sliminess It is different, it is suitably added the digestive juice of 1~2 times of volume, then vortex oscillation 30s, places 15min under room temperature.Irrigation of bronchus The processing of liquid sample is the same with sputum specimen.1~2 times of volume volume is suitably added after pleural effusion sample 5000rpm centrifugation 15min Digestive juice, remainder handles same sputum specimen.Swab specimen is first put into 1ml physiological saline, takes out swab after rotating repeatedly, then 5000rpm is centrifuged 15min, and 1ml digestive juice is added, and remainder handles same sputum specimen.(b) the postdigestive liquid of 1ml is drawn to 1.5ml In microcentrifugal tube, 13000rpm is centrifuged 10min.(c) 1ml physiological saline, 13000g centrifugation is added after discarding supernatant liquid 10min.(d) step (c) is repeated after discarding supernatant.Supernatant is removed after centrifugation, 40 μ l DNA extracting solutions are added, and oscillation mixes 2000rpm is centrifuged 5s afterwards, then 37 DEG C of warm bath 30min, then 100 DEG C of heating 10min, and 13000rpm is centrifuged 10min after cooling. (e) supernatant comprising DNA profiling is transferred to another after being centrifuged to go in the 1.5ml microcentrifugal tube of nucleic acid, sets -20 DEG C of guarantors It deposits spare;
(2) isothermal amplification: the measuring samples DNA profiling obtained in 2 μ L steps (1) or positive and negative control is taken to be added It is mixed in LAMP reaction system, 65 DEG C of isothermal reaction 50min are expanded, and then 80 DEG C of isothermal reaction 10min terminate reaction;Institute State the LAMP detection primer group comprising mycobacterium kansasii described in claims 1 or 2 in LAMP reaction system;
(3) result judges: being judged by the real-time fluorescence detection data of analysis of fluorescence quantitative PCR apparatus, or passes through addition The variation of liquid color carrys out judging result in color developing agent observation PCR pipe.
10. the side of mycobacterium kansasii LAMP detection kit detection mycobacterium kansasii according to claim 9 Method, which is characterized in that LAMP reaction system is to contain in 20 μ L reaction systems:
Outer primer F3, outer primer B3, inner primer FIP, inner primer BIP, ring primer LF and ring primer LB concentration are 10 μM, are added Amount is respectively 0.5 μ L, 0.5 μ L, 2 μ L, 2 μ L, 1 μ L, 1 μ L;
The additional amount of 0.16U/ μ L Bst archaeal dna polymerase is 0.4 μ L;
0.4 μ L of fluorescent dye or color developing agent;
10 μ L of reaction solution includes 4mM dNTP, 12mM MgSO4,1.6mM glycine betaine, 40mM Tris-HCl, 20mM in reaction solution KCl、20mM(NH4)SO4, 0.1%TritonX-100;
The measuring samples DNA extracted in 2 μ L steps (1);
With deionized water polishing to 20 μ L.
CN201810473250.5A 2018-05-16 2018-05-16 LAMP detection primer group, detection kit and its detection method of mycobacterium kansasii Pending CN109280711A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810473250.5A CN109280711A (en) 2018-05-16 2018-05-16 LAMP detection primer group, detection kit and its detection method of mycobacterium kansasii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810473250.5A CN109280711A (en) 2018-05-16 2018-05-16 LAMP detection primer group, detection kit and its detection method of mycobacterium kansasii

Publications (1)

Publication Number Publication Date
CN109280711A true CN109280711A (en) 2019-01-29

Family

ID=65185720

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810473250.5A Pending CN109280711A (en) 2018-05-16 2018-05-16 LAMP detection primer group, detection kit and its detection method of mycobacterium kansasii

Country Status (1)

Country Link
CN (1) CN109280711A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109897889A (en) * 2019-04-17 2019-06-18 北京天恩泽基因科技有限公司 A kind of LAMP(ring mediated isothermal amplification) product visible detection method
CN110273015A (en) * 2019-07-31 2019-09-24 四川省疾病预防控制中心 A kind of mycobacterium kansasii visible detection method based on LAMP technology
CN110872614A (en) * 2019-12-05 2020-03-10 深圳市第三人民医院 Cas12 a/gRNA-based method for rapidly identifying mycobacteria
CN112538540A (en) * 2020-11-26 2021-03-23 中国医学科学院北京协和医院 Kit and system for detecting mycobacterium kansasii
CN113249516A (en) * 2020-02-10 2021-08-13 华南理工大学 Primer group of 2019-nCoV and 2019-nCoV nucleic acid detection kit

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005204582A (en) * 2004-01-23 2005-08-04 Asahi Kasei Corp Oligonucleotide and method for detecting atypical acid-fast bacterium group by using the same
CN1995380A (en) * 2006-01-05 2007-07-11 中国人民解放军总医院第二附属医院 Method for detecting and identifying mycobacterium tuberculosis strain and its dedicated reagent kit
CN101175852A (en) * 2005-05-13 2008-05-07 和光纯药工业株式会社 Primer and probe for use in detection of mycobacterium kansasii and method for detection of mycobacterium kansasii using the same
CN101285062A (en) * 2008-04-29 2008-10-15 博奥生物有限公司 Process for abstracting bacterial DNA from phlegm, kit and uses thereof
CN107099601A (en) * 2017-05-27 2017-08-29 中国人民解放军白求恩国际和平医院 RT LAMP detect Primer composition, corresponding kit and the detection method of viable bacteria of Mycobacterium tuberculosis through

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005204582A (en) * 2004-01-23 2005-08-04 Asahi Kasei Corp Oligonucleotide and method for detecting atypical acid-fast bacterium group by using the same
CN101175852A (en) * 2005-05-13 2008-05-07 和光纯药工业株式会社 Primer and probe for use in detection of mycobacterium kansasii and method for detection of mycobacterium kansasii using the same
CN1995380A (en) * 2006-01-05 2007-07-11 中国人民解放军总医院第二附属医院 Method for detecting and identifying mycobacterium tuberculosis strain and its dedicated reagent kit
CN101285062A (en) * 2008-04-29 2008-10-15 博奥生物有限公司 Process for abstracting bacterial DNA from phlegm, kit and uses thereof
CN107099601A (en) * 2017-05-27 2017-08-29 中国人民解放军白求恩国际和平医院 RT LAMP detect Primer composition, corresponding kit and the detection method of viable bacteria of Mycobacterium tuberculosis through

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ELVIRA RICHTER等: "Identification of Mycobacterium kansasii by Using a DNA Probe (AccuProbe) and Molecular Techniques", 《JOURNAL OF CLINICAL MICROBIOLOGY》 *
MIAO YANG等: "Isolation of a DNA Probe for Identification of Mycobacterium kansasii, Including the Genetic Subgroup", 《JOURNAL OF CLINICAL MICROBIOLOGY》 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109897889A (en) * 2019-04-17 2019-06-18 北京天恩泽基因科技有限公司 A kind of LAMP(ring mediated isothermal amplification) product visible detection method
CN110273015A (en) * 2019-07-31 2019-09-24 四川省疾病预防控制中心 A kind of mycobacterium kansasii visible detection method based on LAMP technology
CN110273015B (en) * 2019-07-31 2023-10-13 四川省疾病预防控制中心 LAMP technology-based visual detection method for mycobacterium kansasii
CN110872614A (en) * 2019-12-05 2020-03-10 深圳市第三人民医院 Cas12 a/gRNA-based method for rapidly identifying mycobacteria
CN113249516A (en) * 2020-02-10 2021-08-13 华南理工大学 Primer group of 2019-nCoV and 2019-nCoV nucleic acid detection kit
CN113249516B (en) * 2020-02-10 2023-04-25 华南理工大学 Primer group of 2019-nCoV and 2019-nCoV nucleic acid detection kit
CN112538540A (en) * 2020-11-26 2021-03-23 中国医学科学院北京协和医院 Kit and system for detecting mycobacterium kansasii
CN112538540B (en) * 2020-11-26 2022-11-22 中国医学科学院北京协和医院 Kit and system for detecting mycobacterium kansasii

Similar Documents

Publication Publication Date Title
CN109280711A (en) LAMP detection primer group, detection kit and its detection method of mycobacterium kansasii
CN106434882B (en) Method for rapidly detecting cronobacter sakazakii at constant temperature, primer and application
CN103436602A (en) Kit and method for simultaneous detection of Staphylococcus aureus gene and Escherichia coli gene by using dual molecular beacon-LAMP process
CN109234419A (en) Bacillus anthracis double fluorescent quantitative PCR detection kit and detection method
CN111154900B (en) Pseudomonas aeruginosa specific new molecular target and rapid detection method thereof
García-Quintanilla et al. Simultaneous identification of Mycobacterium genus and Mycobacterium tuberculosis complex in clinical samples by 5′-exonuclease fluorogenic PCR
CN107663545A (en) Detect primer sets and the application of yersinia enterocolitica
CN111073986B (en) Rapid constant-temperature detection method for salmonella, primer group and application
CN106434890B (en) Method, primer and kit for rapidly detecting yersinia enterocolitica at constant temperature
CN105274193A (en) Mycobacterium tuberculosis constant temperature rapid detection kit through LAMP method and detection method
Zukowska Advanced methods of bacteriological identification in a clinical microbiology laboratory
CN111004854B (en) Rapid constant temperature detection method, primer set and kit for vibrio vulnificus and vibrio cholerae simultaneously
CN104404132B (en) A kind of SS2-LAMP detection kit of streptococcus suis 2-type and application
CN111500751A (en) Detection method and kit for rapidly detecting high-toxicity Klebsiella pneumoniae
CN107557456A (en) The LAMP detection primer group and kit of ureaplasma urealyticum
CN114196767B (en) Specific molecular target and method for detecting staphylococcus aureus ST type by using same
CN1987428A (en) Method for quick detecting functional bacterial content in waste water treating system
CN111004856B (en) Rapid constant-temperature detection method, primer group and kit for vibrio vulnificus
CN107604085A (en) LAMP detection primer group, kit and the method for ureaplasma parvum
CN108103153A (en) A kind of LAMP detection primer combination of wheat powdery mildew and its LAMP detection kit and LAMP method
Garberi et al. Rapid and safe diagnosis of Mycobacterium tuberculosis directly from sputum and biological fluids specimens using a low cost molecular biology dedicated system
MICRO-ORGANISMS 5.1. 6. ALTERNATIVE METHODS FOR CONTROL OF MICROBIOLOGICAL QUALITY

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190129

RJ01 Rejection of invention patent application after publication